Dealsphere will be officially unveiled at the Nutrify C-Suite Sumflex event
Nutrify Today, a pioneer in AI-driven nutraceutical innovation, has introduced Dealsphere, a groundbreaking platform that transforms how businesses discover, license, and commercialise science-backed nutrition products.
Dealsphere accelerates the traditionally slow and expensive process of product ideation and licensing, enabling companies to launch new nutraceutical products in a matter of days, a significant reduction from the years it typically takes. This innovation builds on Nutrify Today’s 2023 success with the world’s first precision AI for nutraceuticals, which reduced product development time from 1.5 years to nine months.
For pharmaceutical and nutraceutical companies, securing innovative, scientifically proven formulas has traditionally been a long and costly process involving extensive negotiations and research. Dealsphere eliminates these barriers, offering an Amazon-like experience for licensing high-science, responsible nutrition products, thereby simplifying and streamlining the process.
With Dealsphere, companies can now browse pre-approved, science-backed formulations, select a formula that aligns with their brand and budget, and launch new products in days with full regulatory compliance.
Dealsphere will be officially unveiled at the Nutrify C-Suite Sumflex event. Ahead of the launch, NutrifyGenie AI introduced Multimillion-Dollar Playbook, a book featuring the first 100 commercially viable formulas across all three grades. The book’s soft launch on Amazon India saw it sell out within 30 minutes, a testament to the strong industry demand for fast, validated nutraceutical innovations and the confidence in NutrifyGenie AI’s capabilities.